PCML
GMAB icon

Pavaki Capital Management LLC’s Genmab GMAB Stock Holding History

Pavaki Capital Management LLC’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Hold
8,000
– – 0.08% 127
2026
Q1 		$215K Buy
+8,000
New +$240K 0.09% 122

Other funds holding GMAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Pavaki Capital Management LLC's GMAB Position: Q2 2026 in Review

Pavaki Capital Management LLC held its Genmab (GMAB) position steady in Q2 2026 at 8,000 shares worth $220K. The position accounts for 0.08% of the portfolio, ranked #127.

Pavaki Capital Management LLC first reported a position in GMAB in Q1 2026 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Pavaki Capital Management LLC held 8,000 shares of Genmab worth $220K as of Q2 2026.
  • Pavaki Capital Management LLC left its Genmab share count unchanged in Q2 2026.
  • Genmab made up 0.08% of Pavaki Capital Management LLC's portfolio in Q2 2026, its #127 holding.
  • Pavaki Capital Management LLC first reported a position in Genmab in Q1 2026 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Pavaki Capital Management LLC's 13F filing for Q2 2026, filed 7 Aug 2026.